Production (Stage)
The Cigna Group
CI
$315.99
$3.311.06%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 1.32B | 1.42B | 739.00M | 1.55B | -277.00M |
Total Depreciation and Amortization | 674.00M | -375.00M | 650.00M | 738.00M | 741.00M |
Total Amortization of Deferred Charges | -- | 1.02B | -- | -- | -- |
Total Other Non-Cash Items | -169.00M | 170.00M | 942.00M | 32.00M | 1.82B |
Change in Net Operating Assets | 92.00M | 2.97B | -2.29B | -2.05B | 2.56B |
Cash from Operations | 1.92B | 5.21B | 46.00M | 265.00M | 4.84B |
Capital Expenditure | -327.00M | -337.00M | -399.00M | -370.00M | -300.00M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | 1.00M | -132.00M | -- | -- |
Divestitures | 2.35B | 521.00M | -- | -- | -- |
Other Investing Activities | -822.00M | -376.00M | -245.00M | -270.00M | -195.00M |
Cash from Investing | 1.20B | -191.00M | -776.00M | -640.00M | -495.00M |
Total Debt Issued | -- | -366.00M | 366.00M | 0.00 | 4.46B |
Total Debt Repaid | -1.59B | -402.00M | 467.00M | -893.00M | -2.57B |
Issuance of Common Stock | 69.00M | 22.00M | 62.00M | 40.00M | 181.00M |
Repurchase of Common Stock | -1.51B | -2.02B | 0.00 | -990.00M | -4.02B |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -412.00M | -384.00M | -390.00M | -392.00M | -401.00M |
Other Financing Activities | -239.00M | -96.00M | -66.00M | -74.00M | -175.00M |
Cash from Financing | -3.68B | -3.25B | 439.00M | -2.31B | -2.53B |
Foreign Exchange rate Adjustments | 9.00M | -26.00M | 18.00M | -3.00M | -9.00M |
Miscellaneous Cash Flow Adjustments | -- | -90.00M | -1.25B | -- | -- |
Net Change in Cash | -555.00M | 1.66B | -1.52B | -2.69B | 1.81B |